AZD-1656

Item number	Size	Delivery time	Price
TGM-T26712-1mg	1 mg	7 - 10 business days*	83.00€
TGM-T26712-2mg	2 mg	7 - 10 business days*	122.00€
TGM-T26712-5mg	5 mg	7 - 10 business days*	198.00€
TGM-T26712-1mL	1 ml	7 - 10 business days*	215.00€
TGM-T26712-10mg	10 mg	7 - 10 business days*	327.00€
TGM-T26712-25mg	25 mg	7 - 10 business days*	660.00€
TGM-T26712-50mg	50 mg	7 - 10 business days*	993.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia... more

Close menu

Product information "AZD-1656"

Description: AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes. Target: Glucokinase. Smiles: COC[C@H](C)Oc1cc(Oc2cnc(cn2)C(=O)N2CCC2)cc(c1)C(=O)Nc1cnc(C)cn1. References: Krentz AJ, et al. Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin. Diabetes Obes Metab. 2014 Nov,16(11):1096-101.

Keywords:	AZD 1656
Supplier:	TargetMol
Supplier-Nr:	T26712

Properties

MW:	478.5 D
Formula:	C24H26N6O5

Database Information

CAS :

919783-22-5| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "AZD-1656"

Write a review